

Publisher: Karger
E-ISSN: 2296-5262|29|10|426-428
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.29, Iss.10, 2006-09, pp. : 426-428
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


Gabapentin for the Treatment of Cancer-Related Pain Syndromes
Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. :





